Home / Psoriasis (page 20)


Here you will find the latest clinical research on psoriasis.

APremilast After FumaRic Acid Ester Treatment (APART)

  Purpose Patient treatment preference and treatment satisfaction of physicians and patients comparing fumaric acid ester therapy with subsequent apremilast treatment Condition Intervention Psoriasis Drug: Phase I: Fumaric acid esters. Phase II: Apremilast Study Type: Observational Study Design: Observational Model: OtherTime Perspective: Prospective Official Title: Real-world Benefit of Apremilast Treatment …

Read More »

BE Study in Patients – Methotrexate Tablets

  Purpose To characterize the pharmacokinetic profile of the Test product – Methotrexate Tablets USP, 2.5 mg of Amneal Pharmaceuticals, compared to that of the corresponding Reference product – Methotrexate Tablets USP 2.5 mg manufactured for DAVA Pharmaceuticals, Inc. in patients with mild to severe psoriasis or rheumatoid arthritis, who …

Read More »

Study of the Efficacy of Early Intervention With Secukinumab 300 mg s.c. Compared to Narrow-band UVB in Patients With New-onset Moderate to Severe Plaque Psoriasis (STEPin)

  Purpose The purpose of this study is to determine whether early intervention with subcutaneous (s.c.) secukinumab 300 mg in patients with new-onset moderate to severe plaque psoriasis may lead to prolonged symptom free periods by preventing reactivation of old lesions or ultimately totally hindering the occurrence of new lesions, …

Read More »

PET/CT in Psoriatic Arthritis

  Purpose When patients with psoriasis develop joint pain, it is often hard to decide whether or not the pain is due to psoriatic arthritis (PsA). At this time, doctors use information from the history and physical exam to determine the diagnosis. X-rays, magnetic resonance imaging (MRI) and ultrasound have …

Read More »

LEO 90100 Twice Weekly Maintenance Regimen for Psoriasis Vulgaris

  Purpose A phase 3 trial comparing the efficacy and safety of LEO 90100 aerosol foam with the aerosol foam vehicle used twice weekly as long-term maintenance therapy in subjects with psoriasis vulgaris. A 12-month, international, multi-centre, randomised, vehicle controlled, double-blind, 2-arm, parallel group trial. Condition Intervention Phase Psoriasis Vulgaris …

Read More »

Swiss Dermatology Network of Targeted Therapies (SDNTT) (SDNTT)

  Purpose The purpose of this study is to evaluate the long-term course of patients with psoriasis and psoriatic-arthritis in systemic treatments such as, methotrexate, cyclosporin A, fumaric acids, acitretin, systemic PUVA, etanercept, infliximab, adalimumab and ustekinumab. A patient will be included at first initiation of the treatment and will …

Read More »